Attenuation of Portal Hypertension by Continuous Portal Infusion of PGE1 and Immunologic Impact in Adult-to-Adult Living-Donor Liver Transplantation

Background Small-for-size syndrome remains the greatest limiting factor of expanding segmental liver transplantation from living donors. Portal hyperperfusion is considered to substantially contribute to small-for-size syndrome. We investigated the impact of continuous portal infusion of prostaglandin E1 (PGE1) on small-for-size grafts (SFSGs) in adult-to-adult living-donor liver transplantation (LDLT). Methods From July 2003 to December 2009, LDLT was performed in 122 patients. We introduced continuous portal infusion of PGE1 to five SFSG patients (PG group) from November 2007 to December 2009 and retrospectively compared them with a historical control group of eight relevant SFSG patients without PGE1 infusion (non-PG group) from July 2003 to October 2007 to determine the safety and efficacy of continuous PGE1 portal infusion for SFSGs. Splenectomy cases were excluded from analysis. Results The PG group demonstrated significantly lower postoperative portal pressure than the non-PG group. Moreover, the PG group demonstrated significantly improved liver function in the early posttransplantation period and significantly better recovery from hyperammonemia at 1 week after transplantation and from hyperbilirubinemia in the late posttransplantation period. Overall survival was significantly better in the PG group than in the non-PG group. Three patients in the non-PG group died of rejection-related reasons. Interestingly, immunomonitoring assay revealed that antidonor immune responses were significantly accelerated in the non-PG group compared with the PG group after LDLT. In contrast, the PG group showed well-suppressed antidonor immune responses. Conclusion Continuous portal infusion of PGE1 for SFSG attenuated portal hypertension, improved graft function, and suppressed antidonor immune responses, resulting in better survival.

[1]  Z. Liu,et al.  Small for size syndrome following living donor and split liver transplantation. , 2010, World journal of gastrointestinal surgery.

[2]  S. Uemoto,et al.  Portal pressure <15 mm Hg is a key for successful adult living donor liver transplantation utilizing smaller grafts than before , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[3]  J. Botha,et al.  Fifteen millimeters of mercury , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[4]  J. Roberts,et al.  Left lobe adult‐to‐adult living donor liver transplantation: Small grafts and hemiportocaval shunts in the prevention of small‐for‐size syndrome , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[5]  K. Kim,et al.  Dual living donor liver transplantation with ABO‐incompatible and ABO‐compatible grafts to overcome small‐for‐size graft and ABO blood group barrier , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[6]  Lunan Yan,et al.  Prevent small-for-size syndrome using dual grafts in living donor liver transplantation. , 2009, The Journal of surgical research.

[7]  T. Asahara,et al.  ABO‐blood type incompatible living donor liver transplantation in a patient with Budd‐Chiari Syndrome secondary to essential thrombocythemia , 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

[8]  T. Asahara,et al.  Using Recipient’s Middle Hepatic Vein for Drainage of the Right Paramedian Sector in Right Liver Graft , 2008, Transplantation.

[9]  N. Tanaka,et al.  Effects of Prophylactic Splenic Artery Modulation on Portal Overperfusion and Liver Regeneration in Small-for-Size Graft , 2008, Transplantation.

[10]  Y. Maehara,et al.  The beneficial role of simultaneous splenectomy in living donor liver transplantation in patients with small‐for‐size graft , 2008, Transplant international : official journal of the European Society for Organ Transplantation.

[11]  H. Senturk,et al.  Splenic abscess after splenic artery ligation in living donor liver transplantation: a case report. , 2008, Transplantation proceedings.

[12]  O. Dirsch,et al.  Induction of Rejection After Small-for-Size Liver Transplantation: Size Matters , 2008, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[13]  T. Asahara,et al.  Microsurgical hepatic artery reconstruction during living‐donor liver transplantation by using head‐mounted surgical binocular system , 2007, Transplant international : official journal of the European Society for Organ Transplantation.

[14]  I. Endo,et al.  Pharmacologic preconditioning effects: Prostaglandin E1 induces heat-shock proteins immediately after ischemia/reperfusion of the mouse liver , 2005, Journal of Gastrointestinal Surgery.

[15]  K. Arihiro,et al.  Liver Sinusoidal Endothelial Cells That Endocytose Allogeneic Cells Suppress T Cells with Indirect Allospecificity1 , 2006, The Journal of Immunology.

[16]  T. Asahara,et al.  Near‐Infrared Spectroscopic Analysis of Hemodynamics and Mitochondrial Redox in Right Lobe Grafts in Living‐Donor Liver Transplantation , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[17]  P. Clavien,et al.  Small‐for‐Size Syndrome After Partial Liver Transplantation: Definition, Mechanisms of Disease and Clinical Implications , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[18]  T. Asahara,et al.  Liver Sinusoidal Endothelial Cells Tolerize T Cells across MHC Barriers in Mice 1 , 2005, The Journal of Immunology.

[19]  Peter Smeets,et al.  Effects of Hemi‐Portocaval Shunts For Inflow Modulation on the Outcome of Small‐for‐Size Grafts in Living Donor Liver Transplantation , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[20]  T. Asahara,et al.  Low Incidence of Acute Rejection after Living-Donor Liver Transplantation: Immunologic Analyses by Mixed Lymphocyte Reaction using a Carboxyfluorescein Diacetate Succinimidyl Ester Labeling Technique , 2005, Transplantation.

[21]  T. Asahara,et al.  Liver sinusoidal endothelial cells have a capacity for inducing nonresponsiveness of T cells across major histocompatibility complex barriers , 2005, Transplant international : official journal of the European Society for Organ Transplantation.

[22]  Koji Fujii,et al.  Impact of portal venous pressure on regeneration and graft damage after living‐donor liver transplantation , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[23]  Y. Maehara,et al.  The impact of splenectomy or splenic artery ligation on the outcome of a living donor adult liver transplantation using a left lobe graft. , 2004, Hepato-gastroenterology.

[24]  T. Asahara,et al.  Multiparameter Flow Cytometric Approach for Simultaneous Evaluation of Proliferation and Cytokine‐Secreting Activity in T Cells Responding to Allo‐stimulation , 2004, Immunological investigations.

[25]  T. Starzl,et al.  Role of Splenectomy in Human Liver Transplantation Under Modern-Day Immunosuppression , 1998, Digestive Diseases and Sciences.

[26]  T. Asahara,et al.  Intraoperative near-infrared spectroscopy for evaluating hepatic venous outflow in living-donor right lobe liver1 , 2003, Transplantation.

[27]  N. Ohkohchi,et al.  Portal vein pressure is the key for successful liver transplantation of an extremely small graft in the pig model , 2003, Transplant international : official journal of the European Society for Organ Transplantation.

[28]  S. Fan,et al.  Graft Injury in Relation to Graft Size in Right Lobe Live Donor Liver Transplantation: A Study of Hepatic Sinusoidal Injury in Correlation With Portal Hemodynamics and Intragraft Gene Expression , 2003, Annals of surgery.

[29]  P. Morel,et al.  Prostaglandin E(1) protects human liver sinusoidal endothelial cell from apoptosis induced by hypoxia reoxygenation. , 2002, Microvascular research.

[30]  U. Neumann,et al.  Simultaneous splenectomy increases risk for opportunistic pneumonia in patients after liver transplantation , 2002, Transplant international : official journal of the European Society for Organ Transplantation.

[31]  B. Delafosse,et al.  Small-for-size partial liver graft in an adult recipient; a new transplant technique , 2002, The Lancet.

[32]  H. Nanjo,et al.  Continuous arterial infusion of prostaglandin E(1) via the superior mesenteric artery in the treatment of postoperative liver failure. , 2002, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis.

[33]  K. Mystakidou,et al.  Hemodynamic interaction between portal vein and hepatic artery flow in small-for-size split liver transplantation , 2002, Transplant international : official journal of the European Society for Organ Transplantation.

[34]  G. Wakabayashi,et al.  Intraportal perfusion of prostaglandin E1 attenuates hepatic postischaemic microcirculatory impairments in rats , 1999, Journal of gastroenterology and hepatology.

[35]  H. Shimada,et al.  Prostaglandin E1 protects against ischemia-reperfusion injury of the liver by inhibition of neutrophil adherence to endothelial cells. , 1997, Transplantation.

[36]  H. Gudmundsdottir,et al.  Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. , 1997, The Journal of clinical investigation.

[37]  A. Assaad.  Posttransplantation management of the newborn and the immunosuppressive role of prostaglandin E1. , 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[38]  D. Turner,et al.  Fluorescent labeling of dissociated fetal cells for tissue culture , 1992, Journal of Neuroscience Methods.

[39]  S. Kunkel,et al.  CONSTANT INTRARENAL INFUSION OF PGE1 INTO A CANINE RENAL TRANSPLANT USING A TOTALLY IMPLANTABLE PUMP , 1984, Transplantation.